about
Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: association with cigarette smoking and HLA-DRB1 'shared epitope' allelesSerum RANKL levels associate with anti- citrullinated protein antibodies in early untreated rheumatoid arthritis and are modulated following methotrexateParity influences the severity of ACPA-negative early rheumatoid arthritis: a cohort study based on the Swedish EIRA material.Recent infections are associated with decreased risk of rheumatoid arthritis: a population-based case-control study.A Multi-Biomarker Disease Activity Score and the Choice of Second-Line Therapy in Early Rheumatoid Arthritis After Methotrexate FailureCorrelates of Leisure Time Physical Inactivity in a Scandinavian Population: A Basis for Interventions.Association of response to TNF inhibitors in rheumatoid arthritis with quantitative trait loci for and CD39Periodontal Health and Oral Microbiota in Patients with Rheumatoid Arthritis.Anti-Carbamylated Protein Antibodies and Higher Baseline Disease Activity in Rheumatoid Arthritis-A Replication Study in Three Cohorts: Comment on the Article by Truchetet et alRisk of Thyroxine-Treated Autoimmune Thyroid Disease Associated With Disease Onset in Patients With Rheumatoid ArthritisAn updated matrix to predict rapid radiographic progression of early rheumatoid arthritis patients: pooled analyses from several databasesSerum Biomarkers for Prediction of Response to Methotrexate Monotherapy in Early Rheumatoid Arthritis: Results from the SWEFOT TrialOccupational physical workload and development of anti-collagen type II antibodies in rheumatoid arthritis: results from the Swedish EIRA population-based case-control studyPredicting risk for radiographic damage in rheumatoid arthritis: comparative analysis of the multi-biomarker disease activity score and conventional measures of disease activity in multiple studiesOccupational exposure to asbestos and silica and risk of developing rheumatoid arthritis: findings from a Swedish population-based case-control studyAbatacept in rheumatoid arthritis: survival on drug, clinical outcomes, and their predictors-data from a large national quality registerIncidence and risk factors for adalimumab and infliximab anti-drug antibodies in rheumatoid arthritis: A European retrospective multicohort analysisAssociation of female sex and positive rheumatoid factor with low serum infliximab and anti-drug antibodies, related to treatment failure in early rheumatoid arthritis: results from the SWEFOT trial population
P50
Q35136055-E4634D25-3B77-4EBC-8E0C-5BD72E579D86Q36027446-78E46AA3-8884-4051-B59D-9A977220A917Q36439968-3AFFB8D4-A74A-4775-B632-C69FD46735B4Q38416420-10AF8333-0B8D-4D51-BD32-B8F762B91200Q39088676-1BFD40E5-B5E3-4BDB-AB3A-AB63697D6B1FQ40523887-94866D2E-2C55-415F-9EC3-93EF90FCD98BQ64109926-F1226007-7624-4D82-B4EE-9CB38C259A76Q64994712-DCC3EDB8-0C38-47B2-8F2D-6DA75F0207A6Q90603204-AF399BC9-F273-46C9-AB03-0381E34F9FB2Q91057906-8973B00A-FCC6-40EB-8DC9-9EAADD4D0A6CQ91269781-0070E190-E3FC-4F17-B336-B728ADDE5F51Q91312025-E8462852-FDB6-419B-8126-B496DEB79DC3Q91527885-8EB030D4-5B72-47BA-B4C1-46F375A12853Q91685909-C4D492E8-5C37-4961-8082-25F6FEA26104Q92628109-B8819634-B994-4200-8C93-5BFE0535E8D6Q92857546-54065C7E-0A56-4556-A283-200058B50DE7Q93014417-6B1ABC2F-34F1-4B40-9F03-DA2C206EDEE8Q93059811-3557DB4E-806F-4416-A624-5DA1C331D1AC
P50
description
researcher (ORCID 0000-0001-9392-6184)
@en
wetenschapper
@nl
name
S Saevarsdottir
@en
S Saevarsdottir
@nl
type
label
S Saevarsdottir
@en
S Saevarsdottir
@nl
prefLabel
S Saevarsdottir
@en
S Saevarsdottir
@nl
P31
P496
0000-0001-9392-6184